Seattle Genetics stock jumps 17% on breast cancer drug trial success by James Thorne on October 21, 2019October 21, 2019 at 10:35 am Shares of cancer drug maker Seattle Genetics soared more than 17 percent Monday morning following positive results for a new drug that fights aggressive breast cancers. Tucatinib is a daily… Read More